Citigroup initates Rhythm Pharmaceuticals Inc (RYTM) stock to a Buy

Samantha Gray

Rhythm Pharmaceuticals Inc’s recent filing unveils that its Chief Human Resources Officer Cramer Pamela J. unloaded Company’s shares for reported $0.37 million on Dec 11 ’25. In the deal valued at $111.00 per share,3,350 shares were sold. As a result of this transaction, Cramer Pamela J. now holds 20,814 shares worth roughly $2.22 million.

Then, PAMELA CRAMER bought 3,350 shares, generating $350,980 in total proceeds.

Before that, Cramer Pamela J. sold 3,350 shares. Rhythm Pharmaceuticals Inc shares valued at $351,750 were divested by the Chief Human Resources Officer at a price of $105.00 per share. As a result of the transaction, Cramer Pamela J. now holds 20,814 shares, worth roughly $2.22 million.

Citigroup initiated its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy in a research note published on November 25, 2025; the price target was $136. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who decreased its forecast for the stock in early November from “an Outperform” to “a Perform”. Goldman began covering RYTM with “Buy” recommendation on July 10, 2025. Leerink Partners started covering the stock on July 07, 2025. It rated RYTM as “an Outperform”.

Price Performance Review of RYTM

On Tuesday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock fall -5.14% to $106.76. Over the last five days, the stock has lost -5.42%. Rhythm Pharmaceuticals Inc shares have risen nearly 88.82% since the year began. Nevertheless, the stocks have risen 90.71% over the past one year. While a 52-week high of $122.20 was reached on 12/11/25, a 52-week low of $45.90 was recorded on 04/07/25.

Levels Of Support And Resistance For RYTM Stock

The 24-hour chart illustrates a support level at 103.78, which if violated will result in even more drops to 100.80. On the upside, there is a resistance level at 111.96. A further resistance level may holdings at 117.17.

How much short interest is there in Rhythm Pharmaceuticals Inc?

A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2025-12-15, growing by 79078.0 shares to a total of 5.58 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 5.5 million shares. There was a rise of 1.42%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.